| ISPC 0.1365 17.17% | CTNT 0.0953 -40.73% | BYND 0.8226 5.19% | YXT 0.496 34.05% | TZA 5.08 -6.45% | EFOI 6.49 210.53% | TSLL 13.9 6.35% | NVDA 201.68 1.68% | BITO 10.63 2.71% | NFLX 97.31 -9.72% | INTC 68.5 0.00% | ZSPC 0.0536 -38.46% | TQQQ 58.59 3.83% | SOXS 18.87 -6.95% | TSLA 400.62 3.01% | XLE 55.02 -2.76% | AMC 1.86 15.53% | SCO 8.47 9.72% | PLUG 2.78 -2.80% | BMNG 1.6 4.58% | IBIT 43.94 2.83% | AAL 12.78 4.16% | BZAI 2.52 45.66% | CRML 12.56 35.49% | SOFI 19.43 2.10% | HIVE 2.51 14.87% | GRAB 4.21 4.73% | SPY 710.14 1.21% | SQQQ 56.39 -3.79% | SOXL 94.68 7.14% | SMR 12.65 10.87% | BMNR 22.95 2.27% | SNAP 6.03 0.17% | UCAR 1.49 29.57% | HIMS 28.82 6.78% | LZMH 0.1736 -84.07% | HYG 80.65 0.37% | DRIP 5.25 9.83% | ONDS 10 -1.96% | DVLT 0.758 -9.49% | AAPL 270.23 2.59% | QQQ 648.85 1.31% | MARA 11.6 0.43% | MSTR 166.52 11.80% | AMZN 250.56 0.34% | PLTR 146.39 2.54% | SPDN 9.13 -1.19% | PBM 7.6 29.47% | IONQ 46.09 3.16% | MSFT 422.79 0.60%

AudioEye, Inc. (NASDAQ:AEYE) and Its Capital Efficiency Compared to Peers

AudioEye, Inc. (NASDAQ:AEYE) is a company that focuses on digital accessibility solutions, helping businesses make their digital content accessible to individuals with disabilities. The company operates in a competitive landscape with peers like Brightcove Inc., ClearPoint Neuro, Inc., Rekor Systems, Inc., DarioHealth Corp., and Apyx Medical Corporation. These companies, while operating in different sectors, share the common challenge of managing their capital efficiently.

AudioEye's Return on Invested Capital (ROIC) is -14.04%, which is significantly lower than its Weighted Average Cost of Capital (WACC) of 7.73%. This negative ROIC indicates that AudioEye is not generating enough returns to cover its cost of capital, which is a critical measure of financial health. The ROIC to WACC ratio of -1.82 further highlights this inefficiency in capital utilization.

When comparing AudioEye to its peers, Brightcove Inc. emerges as the company with the least negative ROIC to WACC ratio at -1.56. Despite its negative ROIC of -11.66%, Brightcove's WACC is 7.48%, suggesting it is relatively closer to covering its cost of capital compared to others. This positions Brightcove as a relatively better performer in terms of capital efficiency.

ClearPoint Neuro, Inc. and Rekor Systems, Inc. show more significant challenges with ROICs of -40.55% and -107.12%, respectively. Their ROIC to WACC ratios of -5.20 and -8.14 indicate a substantial gap between the returns generated and the cost of capital. This suggests that these companies face more significant hurdles in achieving capital efficiency.

DarioHealth Corp. and Apyx Medical Corporation also struggle with negative ROICs of -18.93% and -26.00%, respectively. Their ROIC to WACC ratios of -2.82 and -2.27 reflect ongoing challenges in generating returns that exceed their cost of capital. These figures underscore the broader issue of capital inefficiency across the peer group, with Brightcove Inc. standing out as the relatively better performer.

Published on: August 13, 2025